| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0009 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.007 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.02 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.03 |